Erwan Martin
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Erwan Martin
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cytomics Pharmaceuticals SA
 Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation.
6
| Extinct | Pharmaceuticals: Major | 6 |
4
| Private Company | Medical Specialties | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Erwan Martin
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Aventis, Inc. | Corporate Officer/Principal | ||
| MEDISTIM ASA | Medical Specialties | Director/Board Member | |
Cellatope Corp.
 Cellatope Corp. Pharmaceuticals: MajorHealth Technology Cellatope Corp. provides medical services. It develops research & diagnostic products and services for autoimmune diseases focusing on lupus. The company was founded by Alumna Valerie Pajak Glyptis in October, 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | President | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Birchmere Ventures, Inc.
 Birchmere Ventures, Inc. Investment ManagersFinance Birchmere Ventures Inc (Birchmere Ventures) is a venture capital firm founded in the year 1996 by Ned Renzi and Sean Sebastian. The firm is headquartered in Pittsburgh, Pennsylvania with an additional office in San Francisco. | Investment Managers | Chief Investment Officer | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director of Finance/CFO | |
| THERADIAG | Medical Specialties | Chief Executive Officer | |
Innovata Ltd.
 Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
| The Rockefeller University | College/University | Doctorate Degree | |
| University of Oslo | College/University | Graduate Degree | |
| Université de Technologie de Compiègne | College/University | Doctorate Degree | |
| ESSEC Business School | College/University | Masters Business Admin | |
Sphere Medical Ltd.
 Sphere Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Sphere Medical Ltd. develops monitoring and diagnostic products to provide clinical and economic benefits in critical care environment. It offers microfabricated and transducers technologies. The company was founded in March 2002 by Gavin Troughton and is headquartered in Cambridge, the United Kingdom. | Electronic Equipment/Instruments | Chief Operating Officer | |
| VERGNET S.A. | Electrical Products | Director of Finance/CFO | |
| CARMAT | Medical Specialties | Founder | |
| DEINOVE | Biotechnology | Founder | |
Microvisk Ltd.
 Microvisk Ltd. Electronic Equipment/InstrumentsElectronic Technology Microvisk Ltd. engages in the manufacture and development of micro-viscometer based on micro electro mechanical sensors technology for medical field. The firm's products include CoagMax, CoagLite, CoagManager and SmartStrip. It develops technology for the detection and analysis of a fluid's properties using a cantilever-based micro-viscometer. The company was founded by Vladislav Djakov, Paul Morgan Vernon and Jeremy Burford Peckham in 2004 and is headquartered in Oxford, the United Kingdom. | Electronic Equipment/Instruments | Chief Operating Officer | |
| The European Association for Bioindustries | Director/Board Member | ||
| Qvint Biotech AS | Founder | ||
Alderys SAS
 Alderys SAS BiotechnologyHealth Technology Alderys SAS engage in the development of approaches to the micro-organic biological engineering of profitable chemical compounds from renewable plant resources. It operates in the following markets: chemicals for generating building block compounds, animal nutrition, and cosmetics. The company was founded by Dominique Thomas on July 30, 2010 and is headquartered in Orsay, France. | Biotechnology | Founder | |
| Institut de Pharmacie Industrielle de Paris | College/University | Undergraduate Degree | |
| NEOMA Business School | College/University | Undergraduate Degree | |
| TMBB Consulting | Corporate Officer/Principal | ||
| Artedrone SAS | Director/Board Member | ||
| Skinosive Sasu | Chairman | ||
| Pk Med SAS | Chairman | ||
| Caranx Medical SAS | Founder | ||
| Bariatek Medical SAS | Director/Board Member | ||
Nadeno Nanoscience AS
 Nadeno Nanoscience AS BiotechnologyHealth Technology Nadeno Nanoscience AS is a company based in Trondheim, Norway. Nadeno is a Sintef spin-off that specializes in nanotechnology drug delivery platforms. The Norwegian company has developed a platform that focuses on unleashing the potential of hard-to-deliver hydrophobic small molecule drugs. The company's technology is designed to address the majority of failures in drug delivery. The company was founded by Annbjørg Falck and Yrr Mørch, with Annbjørg Falck serving as CEO since incorporation. | Biotechnology | Chairman | |
| Spikimm SAS | Chairman | ||
Demeta SAS
 Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Medical Specialties | Founder Chief Operating Officer |
Statistik
International
| Frankreich | 27 |
| Vereinigte Staaten | 14 |
| Norwegen | 6 |
| Vereinigtes Königreich | 6 |
| Belgien | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Finance | 3 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 40 |
| Founder | 27 |
| Corporate Officer/Principal | 18 |
| Chairman | 17 |
| Chief Operating Officer | 6 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Erwan Martin
- Unternehmensverbindungen
